Still Alive...
Ok, I’m out of hibernation now. I recently made some short-term trades in my Roth IRA account. Remember when I backed up the truck in Genzyme (Ticker: GENZ)? Well, I sold off the position on 9/4 @ $63.62 and rolled the money into Garmin (Ticker: GRMN) @ $105.92. On 9/6 I sold Garmin for a quick profit @ $108 and finally added to more Genentech (Ticker: DNA) @ $78.55 on 9/7. Genentech is starting to break out of its yearlong decline. Even the positive clinical trial news on the lung cancer drug, Erbitux, from Imclone Systems couldn’t bring down Genentech. This stock should continue to trend up as we approach the FDA panel meeting on Avastin for breast cancer in December.
0 Comments:
Post a Comment
<< Home